We are dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women.
Subscribe to our mailing list to stay up to date on upcoming events.
Understanding New Changes to the OVA1 Results Report
November 3, 3016
East Coast: 12:30-12:45 p.m. EST
West Coast: 12:30-12:45 p.m. PST
Presented by: Dr. Marra Francis, Chief Medical Officer of Vermillion and Dr. Herb Fritsche, Lab Director of ASPiRA Labs
Register for East Coast, here.
Register for West Coast, here.
Third Quarter 2016 Financial Results and Investor Conference Call
November 10, 2016 at 4:30 p.m. EST
Join by phone:
- Domestic: 1-888-296-4197
- International: 1-719-2462
- Conference ID: 6709878
Join by webcast, here.
Replay dial-in numbers (available through): November 24, 2016
- Domestic: 1-844-512-2921
- International: 1-412-317-6671
- Replay PIN: 6709878
AAGL 45th Annual Global Congress
November 14-18, 2016
The Rosen Hotel
Canaccord Tenuity, Medical Technologies & Diagnostics Forum
November 17, 2016
Westin Grand Central Hotel
New York, New York